[Pharmacogenetics in psychiatry: state of the art]
- PMID: 29383410
- DOI: 10.1007/s00115-017-0479-8
[Pharmacogenetics in psychiatry: state of the art]
Abstract
In this article, the current literature on pharmacogenetics of antidepressants, antipsychotics and lithium are summarized by the section of Neurobiology and Genetics of the German Society of Psychiatry, Psychotherapy and Neurology (DGPPN). The publications of international expert groups and regulatory authorities are reviewed and discussed. In Germany, a statement on pharmacogenetics was also made by the gene diagnostics committee of the Ministry of Health. The DGPPN supports two recommendations: 1) to perform CYP2D6 genetic testing prior to prescription of tricyclic antidepressants and 2) to determine the HLA-B*1502 genotype in patients of Asian origin before using carbamazepine. The main obstacle for a broad application of pharmacogenetic tests in psychiatry remains the lack of large prospective studies, for both single gene-drug pair and cobinatorial pharmacogenetic tests, to evaluate the benefits of genetic testing. Psychiatrists, geneticists and funding agencies are encouraged to increase their efforts for the future benefit of psychiatric patients.
Keywords: Antidepressants; Antipsychotics; Lithium; Personalised medicine; Pharmacokinetics.
Similar articles
-
Genetic testing for CYP2D6 and CYP2C19 suggests improved outcome for antidepressant and antipsychotic medication.Psychiatry Res. 2019 Sep;279:111-115. doi: 10.1016/j.psychres.2018.02.055. Epub 2018 Mar 9. Psychiatry Res. 2019. PMID: 29699889
-
Drugs and depression.Am J Nurs. 1986 Mar;86(3):292-3. Am J Nurs. 1986. PMID: 2869688 No abstract available.
-
Pharmacogenetics and psychoactive drug therapy: ready for the patient?Ther Drug Monit. 2010 Aug;32(4):381-6. doi: 10.1097/FTD.0b013e3181e1a78d. Ther Drug Monit. 2010. PMID: 20526233 Review.
-
High levels of several antipsychotics and antidepressants due to a pharmacogenetic cause: a case report.Pharmacogenomics. 2019 Jun;20(8):567-570. doi: 10.2217/pgs-2019-0037. Pharmacogenomics. 2019. PMID: 31190622
-
Pharmacogenetics to prevent maniac affective switching with treatment for bipolar disorder: CYP2D6.Pharmacogenomics. 2016 Aug;17(12):1291-3. doi: 10.2217/pgs-2016-0105. Epub 2016 Jul 29. Pharmacogenomics. 2016. PMID: 27469479 Review. No abstract available.
Cited by
-
Risk Phenotypes, Comorbidities, Pharmacotherapy, and Electroconvulsive Therapy (ECT) in a Cohort with Difficult-to-Treat Depression in Comparison to an Unmedicated Control Group.Pharmacopsychiatry. 2024 Jul;57(4):191-203. doi: 10.1055/a-2292-1438. Epub 2024 May 2. Pharmacopsychiatry. 2024. PMID: 38698605 Free PMC article.
-
Pharmacogenetic testing and counselling in the community pharmacy: mixed-methods study of a new pharmacist-led service.Int J Clin Pharm. 2023 Dec;45(6):1378-1386. doi: 10.1007/s11096-023-01596-8. Epub 2023 Jun 20. Int J Clin Pharm. 2023. PMID: 37338707 Free PMC article.
-
[Genetically informed treatment in psychiatry: new dynamics through APOE and antibody treatment of Alzheimer's disease].Nervenarzt. 2025 Jun 23. doi: 10.1007/s00115-025-01839-1. Online ahead of print. Nervenarzt. 2025. PMID: 40548968 Review. German.
-
[Genetic diagnostics of mental health disorders in adulthood].Nervenarzt. 2025 Jul;96(4):386-395. doi: 10.1007/s00115-024-01737-y. Epub 2024 Sep 24. Nervenarzt. 2025. PMID: 39316100 Free PMC article. Review. German.
-
The role of genetics and genomics in clinical psychiatry.Dialogues Clin Neurosci. 2018 Sep;20(3):169-177. doi: 10.31887/DCNS.2018.20.3/mhoehe. Dialogues Clin Neurosci. 2018. PMID: 30581286 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials